Cystic fibrosis: new insights from infection to inflammation
DAY 3
Chaired by: Professor Robert Gray (Glasgow) and Dr Dawn Lau (Cardiff)
| 9:00am |
Covering changing microbial ecology and potential new approached such as phage therapy |
| 9:30am |
What can we learn from large animal models of CF and non-CF Bronchiectasis? |
| 10:00am | Exploring how understanding non-pathogen driven autoinflammation may be the key to treating residual inflammation in the CF lung following CFTR modulator therapy Professor Daniel Peckham (Leeds) |
9:00 AM
90 MINUTE SESSION
Learning objectives
- To understand how lung microbiology has changed in CF and how new approaches are needed in anti-microbial therapy.
- To learn how pre-clinical models in CF and non-CF muco-obstructive diseases can lead to the development of new treatments.
- To determine the role of autoinflammatory pathways in CF and how they might be modulated.